A. Rephaeli et al., BUTYRATE-INDUCED DIFFERENTIATION IN LEUKEMIC MYELOID CELLS - IN-VITROAND IN-VIVO STUDIES, International journal of oncology, 4(6), 1994, pp. 1387-1391
A study of the effects of three differentiating agents, butyric acid,
retinoic acid and cytosine arabinoside on proliferation and differenti
ation of primary cultures, obtained from sixteen patients with myelo-p
roliferative disorder was conducted. The results showed that BA was an
effective inhibitor of cell proliferation and inducer of cytodifferen
tiation. An acute non-lymphoblastic leukemia patient was treated with
sodium butyrate. A temporary increase in differentiation-associated pa
rameters were noted. However, the effects of SB were short-lived. The
lack of clinical response led to the development of a BA prodrug pival
oyloxymethylbutyrate (AN-9). This prodrug was more potent in vitro tha
n BA in the induction of cytodifferentiation and inhibition of cell pr
oliferation.